{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:13:07Z","timestamp":1707523987169},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,4]]},"DOI":"10.7759\/cureus.44674","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T23:06:50Z","timestamp":1693868810000},"source":"Crossref","is-referenced-by-count":0,"title":["Daptomycin-Induced Severe Hyperkalemia With Normal Creatine Kinase in a Patient With Methicillin-Resistant Staphylococcus aureus Osteomyelitis"],"prefix":"10.7759","author":[{"given":"Kiranpreet K","family":"Sawhney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatai","family":"Oluyadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1699-3","article-title":"Pathogenesis, diagnosis and management of hyperkalemia","volume":"26","author":"Lehnhardt A","year":"2011","unstructured":"Lehnhardt A, Kemper MJ. Pathogenesis, diagnosis and management of hyperkalemia. Pediatr Nephrol. 2011, 26:377-84. 10.1007\/s00467-010-1699-3","journal-title":"Pediatr Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9858","article-title":"Acute kidney injury and hyperkalemia with precarious electrocardiographic changes caused by concurrent use of telmisartan and diclofenac","volume":"12","author":"Gaba S","year":"2020","unstructured":"Gaba S, Jesrani G, Gupta S, Gupta M. Acute kidney injury and hyperkalemia with precarious electrocardiographic changes caused by concurrent use of telmisartan and diclofenac. Cureus. 2020, 12:e9858. 10.7759\/cureus.9858","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"Einhorn LM","year":"2009","unstructured":"Einhorn LM, Zhan M, Hsu VD, et al.. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med. 2009, 169:1156-62. 10.1001\/archinternmed.2009.132","journal-title":"Arch Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000329511","article-title":"Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race","volume":"120","author":"Hayes J","year":"2012","unstructured":"Hayes J, Kalantar-Zadeh K, Lu JL, Turban S, Anderson JE, Kovesdy CP. Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race. Nephron Clin Pract. 2012, 120:c8-16. 10.1159\/000329511","journal-title":"Nephron Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198511000-00001","article-title":"Drug-induced hyperkalemia","volume":"64","author":"Ponce SP","year":"1985","unstructured":"Ponce SP, Jennings AE, Madias NE, Harrington JT. Drug-induced hyperkalemia. Medicine (Baltimore). 1985, 64:357-70. 10.1097\/00005792-198511000-00001","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1303-9","article-title":"Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals","volume":"69","author":"Ram\u00edrez E","year":"2013","unstructured":"Ram\u00edrez E, Rossignoli T, Campos AJ, et al.. Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals. Eur J Clin Pharmacol. 2013, 69:97-110. 10.1007\/s00228-012-1303-9","journal-title":"Eur J Clin Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11674","article-title":"Daptomycin-induced hyperkalemia as an early sign of rhabdomyolysis in a diabetic patient","volume":"12","author":"Ibarra G","year":"2020","unstructured":"Ibarra G, Elmaaz A, Hennel D, Pacheco E. Daptomycin-induced hyperkalemia as an early sign of rhabdomyolysis in a diabetic patient. Cureus. 2020, 12:e11674. 10.7759\/cureus.11674","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29764","article-title":"Daptomycin-related rhabdomyolysis complicated by severe hyperkalemia and acute kidney injury","volume":"14","author":"Nishimura Y","year":"2022","unstructured":"Nishimura Y. Daptomycin-related rhabdomyolysis complicated by severe hyperkalemia and acute kidney injury. Cureus. 2022, 14:e29764. 10.7759\/cureus.29764","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp140081","article-title":"Daptomycin-induced hyperkalemia in a patient with normal renal function","volume":"71","author":"Budovich A","year":"2014","unstructured":"Budovich A, Blum S, Berger B. Daptomycin-induced hyperkalemia in a patient with normal renal function. Am J Health Syst Pharm. 2014, 71:2137-41. 10.2146\/ajhp140081","journal-title":"Am J Health Syst Pharm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.4.523","article-title":"Development of daptomycin for gram-positive infections","volume":"46","author":"Tally FP","year":"2000","unstructured":"Tally FP, DeBruin MF. Development of daptomycin for gram-positive infections. J Antimicrob Chemother. 2000, 46:523-6. 10.1093\/jac\/46.4.523","journal-title":"J Antimicrob Chemother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx349","article-title":"Daptomycin","volume":"73","author":"Heidary M","year":"2018","unstructured":"Heidary M, Khosravi AD, Khoshnood S, Nasiri MJ, Soleimani S, Goudarzi M. Daptomycin. J Antimicrob Chemother. 2018, 73:1-11. 10.1093\/jac\/dkx349","journal-title":"J Antimicrob Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-015-2515-6","article-title":"Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry","volume":"35","author":"Malizos K","year":"2016","unstructured":"Malizos K, Sarma J, Seaton RA, et al.. Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry. Eur J Clin Microbiol Infect Dis. 2016, 35:111-8. 10.1007\/s10096-015-2515-6","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4077-1","article-title":"Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis","volume":"19","author":"Gaudard P","year":"2019","unstructured":"Gaudard P, Saour M, Morquin D, et al.. Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis. BMC Infect Dis. 2019, 19:438. 10.1186\/s12879-019-4077-1","journal-title":"BMC Infect Dis"},{"key":"ref14","article-title":"Rhabdomyolysis: pathogenesis, diagnosis, and treatment","volume":"15","author":"Torres PA","year":"2015","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015, 15:58-69.","journal-title":"Ochsner J"},{"key":"ref15","article-title":"Rhabdomyolysis","volume":"65","author":"Sauret JM","year":"2002","unstructured":"Sauret JM, Marinides G, Gordon KW. Rhabdomyolysis. Am Fam Physician. 2002, 65:907-13.","journal-title":"Am Fam Physician"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09340817","article-title":"Hyperkalemia across the continuum of kidney function","volume":"13","author":"Palmer BF","year":"2018","unstructured":"Palmer BF, Clegg DJ. Hyperkalemia across the continuum of kidney function. Clin J Am Soc Nephrol. 2018, 13:155-7. 10.2215\/CJN.09340817","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1239","article-title":"Hospital\u2010acquired hyperkalemia events in older patients are mostly due to avoidable, multifactorial, adverse drug reactions","volume":"105","author":"Robert L","year":"2019","unstructured":"Robert L, Ficheur G, D\u00e9caudin B, et al.. Hospital\u2010acquired hyperkalemia events in older patients are mostly due to avoidable, multifactorial, adverse drug reactions. Clin Pharmacol Ther. 2019, 105:754-60. 10.1002\/cpt.1239","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/145427-daptomycin-induced-severe-hyperkalemia-with-normal-creatine-kinase-in-a-patient-with-methicillin-resistant-staphylococcus-aureus-osteomyelitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:18Z","timestamp":1707508698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/145427-daptomycin-induced-severe-hyperkalemia-with-normal-creatine-kinase-in-a-patient-with-methicillin-resistant-staphylococcus-aureus-osteomyelitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.44674","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,4]]}}}